comparemela.com
Home
Live Updates
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome : comparemela.com
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome
/PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,...
Related Keywords
South Korea ,
Daejeon ,
Taejon Gwangyoksi ,
Australia ,
Kirk Druey ,
Jin San Yoo ,
Pharmabcine Inc ,
Ir Pr Team ,
Business Development Team ,
Linkedin ,
Youtube ,
Idiopathic Systemic Capillary Leak Syndrome ,
Clarkson Disease ,
Science Advances ,
Vascular Inflammation Section ,
Orphan Drug Designation ,
Systemic Capillary Leak ,
Age Related Macular Degeneration ,
Tumor Microenvironment ,
Pharmabcine ,
comparemela.com © 2020. All Rights Reserved.